KCT0007210招募中未知
Clopidogrel versus Aspirin MOnotherapy after 1- to 3-month of Dual-antiplatelet thErapy following zotarolimus-eluting Resolute stents implantation
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 3,744
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 84(Year)（—）
- 性别
- All
入选标准
- •1. Patients = 19 years-old.
- •2. Patients who received zotarolimus-eluting stents (Onyx family) implantation for ischemic heart disease
- •3. Provision of informed consent
排除标准
- •1. Patients = 85 years-old.
- •2. Acute myocardial infarction.
- •3. Left main bifurcation lesion requiring 2-stent technique.
- •4. Pregnant women or women with potential childbearing.
- •5. Life expectancy < 1 year.
- •6. Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator.
- •7. Inability to understand or read the informed consent.
研究者
相似试验
招募中
不适用
Clopidogrel versus Aspirin Monotherapy after Percutaneous Coronary Intervention and Standard Dual Antiplatelet Therapy in Patients at High Risk for Recurrent Ischemic EventsDiseases of the circulatory systemKCT0005076Samsung Medical Center5,000
进行中（未招募）
1 期
Aspirin versus Aspirin plus Clopidogrel in Patients Undergoing Transcatheter Aortic ValveReplacement: a Randomized Multicenter Studyvalvular aortic stenosis submitted to TAVIMedDRA version: 20.0Level: PTClassification code 10002918Term: Aortic valve stenosisSystem Organ Class: 10007541 - Cardiac disordersEUCTR2018-000608-40-ITAOU DI BOLOGNA POLICLINICO S.ORSOLA-MALPIGHI762
招募中
不适用
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE TrialIschemic Heart DiseaseNCT05320926Yonsei University3,744
已完成
4 期
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)Coronary Heart DiseaseNCT02044250Seoul National University Hospital5,530
已完成
4 期
SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3Coronary Artery DiseaseNCT04418479Joo-Yong Hahn5,506